These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 19106489)
21. Hormone serum levels and hormone receptor contents of endometria in women with normal menstrual cycles and patients bearing endometrial carcinoma. Spona J; Ulm R; Bieglmayer C; Husslein P Gynecol Obstet Invest; 1979; 10(2-3):71-80. PubMed ID: 535775 [TBL] [Abstract][Full Text] [Related]
22. Delayed puberty induced by chronic suppression of prolactin release in the female rat. Advis JP; White SS; Ojeda SR Endocrinology; 1981 Nov; 109(5):1321-30. PubMed ID: 6271525 [TBL] [Abstract][Full Text] [Related]
23. Radioimmunological measurement of follicle stimulating hormone and prolactin in the dog. Reimers TJ; Phemister RD; Niswender GD Biol Reprod; 1978 Oct; 19(3):673-9. PubMed ID: 102375 [No Abstract] [Full Text] [Related]
24. [Effects of bromocriptine and dopamine on pituitary hormone secretion in women]. Masaoka K; Hosoya N; Mori T; Watanabe H; Ohkura T; Kumasaka T Nihon Sanka Fujinka Gakkai Zasshi; 1982 Dec; 34(12):2155-62. PubMed ID: 6818310 [TBL] [Abstract][Full Text] [Related]
25. Hormonally active doses of isoflavone aglycones promote mammary and endometrial carcinogenesis and alter the molecular tumor environment in Donryu rats. Kakehashi A; Tago Y; Yoshida M; Sokuza Y; Wei M; Fukushima S; Wanibuchi H Toxicol Sci; 2012 Mar; 126(1):39-51. PubMed ID: 22248470 [TBL] [Abstract][Full Text] [Related]
26. Prolactin response to thyrotropin-releasing hormone as a guideline for cyclical mastalgia treatment. Rea N; Bove F; Gentile A; Parmeggiani U Minerva Med; 1997 Nov; 88(11):479-87. PubMed ID: 9433398 [TBL] [Abstract][Full Text] [Related]
27. Chemopreventive effects of hydroxymatairesinol on uterine carcinogenesis in Donryu rats. Katsuda S; Yoshida M; Saarinen N; Smeds A; Nakae D; Santti R; Maekawa A Exp Biol Med (Maywood); 2004 May; 229(5):417-24. PubMed ID: 15096654 [TBL] [Abstract][Full Text] [Related]
28. Biological relevance of decamethylcyclopentasiloxane (D5) induced rat uterine endometrial adenocarcinoma tumorigenesis: Mode of action and relevance to humans. Klaunig JE; Dekant W; Plotzke K; Scialli AR Regul Toxicol Pharmacol; 2016 Feb; 74 Suppl():S44-56. PubMed ID: 26148665 [TBL] [Abstract][Full Text] [Related]
29. Regulation of pituitary gonadotropin-releasing hormone (GnRH) receptors by pulsatile GnRH in female rats: effects of estradiol and prolactin. Duncan JA; Barkan A; Herbon L; Marshall JC Endocrinology; 1986 Jan; 118(1):320-7. PubMed ID: 3000743 [TBL] [Abstract][Full Text] [Related]
30. Disturbance of follicular development and endocrine reactions induced by the antiovulatory effective progesterone antagonist Onapristone. Schubert C; Nishino Y; Michna H Ann Anat; 1995 Mar; 177(2):139-46. PubMed ID: 7741273 [TBL] [Abstract][Full Text] [Related]
31. RU486-treated rats show endocrine and morphological responses to therapies analogous to responses of women with polycystic ovary syndrome treated with similar therapies. Ruiz A; Aguilar R; Tébar AM; Gaytán F; Sánchez-Criado JE Biol Reprod; 1996 Dec; 55(6):1284-91. PubMed ID: 8949885 [TBL] [Abstract][Full Text] [Related]
32. 2-bromo-alpha-ergocryptine mesylate (CB-154) inhibits prolactin and luteinizing hormone secretion in the prepubertal female rat. Shaban MA; Terranova PF Biol Reprod; 1986 Jun; 34(5):788-95. PubMed ID: 3089338 [TBL] [Abstract][Full Text] [Related]
33. Ovary mediates the effects of RU486 given during proestrus on the diestrous secretion of luteinizing hormone in the rat. Tébar M; Ruíz A; Bellido C; Sánchez-Criado JE Biol Reprod; 1996 Jun; 54(6):1266-70. PubMed ID: 8724354 [TBL] [Abstract][Full Text] [Related]
34. [Antigonadotropic actions of prolactin. Study of 10 cases of women with hyperprolactinemia]. Schaison G; Mowszowicz I; Cesselin E; Lagoguey M Nouv Presse Med; 1977 Feb; 6(6):425-8. PubMed ID: 320558 [TBL] [Abstract][Full Text] [Related]
35. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy. Klibanski A; Beitins IZ; Merriam GR; McArthur JW; Zervas NT; Ridgway EC J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260 [TBL] [Abstract][Full Text] [Related]
36. Effects of octamethylcyclotetrasiloxane (D4) on the luteinizing hormone (LH) surge and levels of various reproductive hormones in female Sprague-Dawley rats. Quinn AL; Dalu A; Meeker LS; Jean PA; Meeks RG; Crissman JW; Gallavan RH; Plotzke KP Reprod Toxicol; 2007 Jun; 23(4):532-40. PubMed ID: 17418525 [TBL] [Abstract][Full Text] [Related]
37. Effects of tamoxifen on serum prolactin levels, pituitary immunoreactive prolactin cells and uterine growth in estradiol-treated ovariectomized rats. Spritzer PM; Ribeiro MF; Oliveira MC; Barbosa-Coutinho LM; Silva IS; Dahlem N; Cericatto R; Pavanato MA Horm Metab Res; 1996 Apr; 28(4):171-6. PubMed ID: 8740191 [TBL] [Abstract][Full Text] [Related]
38. Expression of prolactin receptors in rat reproductive tissues during periovulatory prolactin imbalance. Bogorad RL; Kotok T; Smirnov AN; Turovetskii VM; Smirnova OV Bull Exp Biol Med; 2000 Jun; 129(6):608-11. PubMed ID: 11022263 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of prolactin in the last trimester of gestation decreases mammary gland development in gilts. Farmer C; Sorensen MT; Petitclerc D J Anim Sci; 2000 May; 78(5):1303-9. PubMed ID: 10834586 [TBL] [Abstract][Full Text] [Related]
40. Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol. Kojima T; Tanaka T; Mori H Cancer Res; 1994 Mar; 54(6):1446-9. PubMed ID: 8137246 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]